课题基金 / 基金详情

Target Genes of Inflammatory Temporomandibular Pain

Target Genes of Inflammatory Temporomandibular Pain
炎症性颞下颌疼痛的靶基因
批准号:
7322107
负责人:
ZHIGANG David LUO
金额:
$18.55万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2009-06-30

项目摘要

项目成果

ZHIGANG David LUO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic pain is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that cellular mechanisms of chronic pain are poorly understood. Clinical observations and pharmacological data from experimental animal models have indicated that chronic pain states, including that of orofacial pain, derived from different etiologies have distinct biochemical and pharmacological characteristics, suggesting specific mechanisms for different pain states. A large body of experimental data indicates that altered expression of selected genes in sensory neurons and associated segments of spinal cord may play a special role in neuroplasticity contributing to a specific pain state. We hypothesize that changes in expression of specific genes and their related pathways in trigeminal ganglia, subnucleus caudalis and upper cervical spinal cord may be responsible for the development of chronic orofacial pain states after deep temporomandibular joint inflammation. To test this hypothesis, we plan to use Affymetrix gene chips to examine the gene expression profiles in trigeminal ganglia (containing sensory neurons) and the associated subnucleus caudalis/spinal cord segments of male rats with or without deep temporomandibular joint inflammation. We will identify those genes with specific regulation post inflammation that are also associated with the temporal development of chronic pain. Potential pathways underlined by interactions of identified genes or between identified genes and other genes will be studied using computer assisted data mining. Expression of selective genes from the gene chip analysis will be validated with alternative techniques including real-time PCR, in situ hybridization and Western blots. The potential contribution of selective genes to chronic pain development will be determined by pharmacological, and molecular biology approaches in future studies. The outcome of this study should provide a global view of genomic responses in the trigeminal-spinal complex to orofacial deep-tissue inflammation. Identification of specifically regulated genes and pathways under this condition will provide a focused target gene pool for further investigations of molecular mechanisms underlying chronic pain states post temporomandibular joint infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10552492
  • 项目类别:
  • 资助金额:
    $9.59万
  • 财政年份:
    2022
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10452913
  • 项目类别:
  • 资助金额:
    $7.99万
  • 财政年份:
    2021
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10670457
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8364809
  • 项目类别:
  • 资助金额:
    $22.18万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
海外基金